Chemoinformaics analysis of 2,4,6-trihydroxyacetophenone-2,4-di-O?-D-glucopyranoside
Molecular Weight | 492.43 | nRot | 7 |
Heavy Atom Molecular Weight | 464.206 | nRig | 19 |
Exact Molecular Weight | 492.148 | nRing | 3 |
Solubility: LogS | -0.66 | nHRing | 2 |
Solubility: LogP | -2.299 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 1 |
nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 14 | No. of Arom Bond | 6 |
nHA | 14 | APOL | 63.2982 |
nHD | 9 | BPOL | 35.9018 |
QED | 0.165 |
Synth | 4.473 |
Natural Product Likeliness | 1.427 |
NR-PPAR-gamma | 0.025 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.978 |
HIA | 0.984 |
CACO-2 | -6.466 |
MDCK | 0.000249095 |
BBB | 0.593 |
PPB | 0.288202 |
VDSS | 0.32 |
FU | 0.466394 |
CYP1A2-inh | 0.011 |
CYP1A2-sub | 0.014 |
CYP2c19-inh | 0.004 |
CYP2c19-sub | 0.076 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.116 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.131 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.003 |
CL | 1.427 |
T12 | 0.388 |
hERG | 0.028 |
Ames | 0.141 |
ROA | 0.027 |
SkinSen | 0.015 |
Carcinogencity | 0.148 |
EI | 0.008 |
Respiratory | 0.022 |
NR-Aromatase | 0.01 |
Antiviral | Yes |
Prediction | 0.537467 |